Abstract 13307: An Oral Antisense Oligonucleotide for PCSK9 Inhibition in Humans
Gennemark, Peter, Walter, Katrin, Clemmensen, Niclas, Rekic, Dinko, Nilsson, Catarina, Knoechel, Jane, Holtta, Mikko, Wang, Yanfeng, Yu, Rosie, riney, stanley, Monia, Brett P, Andersson, Ulf, Jansson-Lofmark, Rasmus, Rocha, Cristina S, Linden, Daniel, Ryden-Bergsten, Kristina, Hurt-Camejo, Eva, CROOKE, Rosanne M, Tillman, Lloyd, Carlsson, Bjorn, Elebring, Marie, Tivesten, Anna, Davies, Nigel
Published in Circulation (New York, N.Y.) (17.11.2020)
Published in Circulation (New York, N.Y.) (17.11.2020)
Get full text
Journal Article
Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
Falkenhagen, Undine, Knöchel, Jane, Kloft, Charlotte, Huisinga, Wilhelm
Published in CPT: pharmacometrics and systems pharmacology (01.04.2023)
Published in CPT: pharmacometrics and systems pharmacology (01.04.2023)
Get full text
Journal Article
Abstract 9747: Safety, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD8233, Targeting PCSK9, in Patients with Dyslipidemia
Hofherr, Alexis, Nilsson, Catarina A, Rekic, Dinko, Knoechel, Jane, Goldwater, Ronald, Han, David, Kusnir, Jorge, Overcash, J. Scott, Waters, Michael, White, Alexander, Hurt-Camejo, Eva, Wernevik, Linda, Isaksson, Rikard, Wang, Yanfeng, Bhanot, Sanjay, Ryden-Bergsten, Kristina, Koren, Michael, Carlsson, Bjorn C
Published in Circulation (New York, N.Y.) (16.11.2021)
Published in Circulation (New York, N.Y.) (16.11.2021)
Get full text
Journal Article